| Market Cap | 6.5B |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | -0.34 |
| Dividend Yield | - |
| D/E Ratio | 0.75 |
| Current Ratio | 1.38 |
| Market Segment | STAR Market |
| Currency | CNY |
Business Overview
Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. The company offers anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its name to Jiangsu Aidea Pharmaceutical Group Co., Ltd. in July 2025. The company was founded in 2009 and is headquartered in Yangzhou, China.
Key Financial Metrics
Profitability
Returns & Efficiency
Financial Health
| Industry | Pharmaceutical Manufacturing |
| Market Segment | STAR Market |
| Currency | CNY |
| Fiscal Year | 2024 |
Stock Chart
Full charting with technical indicators, candlestick, line charts, and more.
Company Profile
| Company Name | 艾迪药业 |
| Ticker | 688488 |
| Exchange | SSE |
| Sector | CSRC Classification |
| Industry | Pharmaceutical Manufacturing |
| Market Segment | STAR Market |
| Fiscal Year | 2024 |
| Currency | CNY |
| Market Cap | 6.5B |
| Revenue | 418.0M |
| Net Income | -139.0M |
| P/E Ratio | - |
| EPS | -0.34 |
| Net Margin | -33.3% |
| ROE | -13.0% |
| Dividend Yield | - |
Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. The company offers anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its name to Jiangsu Aidea Pharmaceutical Group Co., Ltd. in July 2025. The company was founded in 2009 and is headquartered in Yangzhou, China.